The Administrative Core provides oversight to the SPORE and provides the framework for a comprehensive coordination of Projects, Cores, Career Development and Developmental Pilot Programs. The work of the Core is coordinated by the SPORE PI and co-PI's working with the Executive Committee (EC). The EC is responsible for evaluating Projects on a regular basis, setting budgets, and when appropriate promoting Developmental Pilot Projects and research done as part of the Career Development Awards as full Projects. The planning and evaluation process of the Core is accomplished through monthly meetings of the EC. In addition, the EC and the Core are responsible for competing the Developmental Pilot Program and the Career Development Awards. The Core also is responsible for coordinating reviews by the Internal and External Advisory Committees, reporting progress to the NCI at regular intervals, and coordinating SPORE related continuing education to both internal and external audiences. The Core also manages any SPORE supplements and coordinates joint activities with other SPOREs, NCI, EDRN, GOG, PLCO, and other collaborative groups. Going fonward the Core will also take responsibility for coordinating the International Ovarian Cancer Community through a biannual ovarian cancer research meetings held in Greece.

Public Health Relevance

The Administrative Core is necessary for evaluating, executing, and coordinating the activities of the Projects, Cores, Developmental Pilot Programs, Career Development Awards, and other inter-SPORE and collaborative efforts.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
7P50CA083638-15
Application #
8474627
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
15
Fiscal Year
2013
Total Cost
$109,842
Indirect Cost
$26,861
Name
Research Institute of Fox Chase Cancer Center
Department
Type
DUNS #
064367329
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Zhong, Qian; Peng, Hong-Ling; Zhao, Xia et al. (2015) Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis. Clin Cancer Res 21:211-20
Duraiswamy, Jaikumar; Freeman, Gordon J; Coukos, George (2014) Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response. Cancer Res 74:633-4; discussion 635
Li, Chunsheng; Wang, Junying; Hu, Jia et al. (2014) Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer. Oncotarget 5:6994-7012
Hu, Xiaowen; Feng, Yi; Zhang, Dongmei et al. (2014) A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 26:344-57
Matthaiou, Efthymia-Iliana; Barar, Jaleh; Sandaltzopoulos, Raphael et al. (2014) Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer. Int J Nanomedicine 9:1855-70
Do, T-V; Xiao, F; Bickel, L E et al. (2014) Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion. Oncogene 33:539-49
Zhang, S; Mercado-Uribe, I; Xing, Z et al. (2014) Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 33:116-28
Feng, Yi; Hu, Xiaowen; Zhang, Youyou et al. (2014) Methods for the study of long noncoding RNA in cancer cell signaling. Methods Mol Biol 1165:115-43
Liu, Hanqing; Beck, Tim N; Golemis, Erica A et al. (2014) Integrating in silico resources to map a signaling network. Methods Mol Biol 1101:197-245
Ye, Qunrui; Song, De-Gang; Poussin, Mathilde et al. (2014) CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor. Clin Cancer Res 20:44-55

Showing the most recent 10 out of 252 publications